Ignite Creation Date:
2024-05-06 @ 1:35 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04068753
Status:
RECRUITING
Last Update Posted:
2024-05-10
First Post:
2019-08-22
Brief Title:
Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix Cancer
Sponsor:
University of Oklahoma
Organization:
University of Oklahoma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-26
Start Date Type:
ACTUAL
Primary Completion Date:
2025-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-07
Completion Date Type:
ESTIMATED
First Submit Date:
2019-08-22
First Submit QC Date:
August 22 2019
Study First Post Date:
2019-08-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-09
Last Update Post Date:
2024-05-10
Last Update Post Date Type:
ACTUAL